The final green light backs NHS use of the drug
News
AZ seals deal with EC for coronavirus vaccine supply
Up to 400 million doses of AZD1222 will be supplied to EU member states under the deal
The end of Public Health England?
Media reports suggest that the body will be ‘scrapped and replaced’ to improve pandemic protection in the country
Galapagos signs deal with Scipher for IBD drug development
Companies will jointly validate novel IBD targets
Novo Nordisk resumes late-stage haemophilia trials
Clinical trial programme resumes after safety concerns
AstraZeneca ships first doses of flu vaccine
Company will manufacture over 25% more doses than previously planned
UK inks further coronavirus vaccine deals
Deals agreed with Janssen and Novavax for another 90 million doses
F2G raises $60.8m to support late-stage antifungal clinical programme
Funding will support development of novel antifungal asset olorofim
FDA accepts application for self-administered Xolair use
If approved drug would offer a more flexible option for patients
New COVID-19 contact tracing app set to launch trial in England
Public trial will launch today in Isle of Wight and other locations
Celleron picks up discarded cancer drug from Roche
UK biopharma company signs licensing agreement for emactuzumab
Gilead aims for approval of COVID-19 drug remdesivir in the US
Drug has already been approved in the EU and Japan
Demand for mental health services to rise due to COVID-19, report finds
NHS Confederation forecasts a surge in demand
BMS’ Opdivo improves survival in gastric and oesophageal cancers
Topline results published from CheckMate-649 and CheckMate-577 studies
Bayer expands women’s health pipeline with KaNDy acquisition
Deal will include access to investigational menopause drug
